Forager Capital Makes $4.80 Per Share All-Cash Bid for RPAY—Board Faces Buyout Decision at 75% Premium


Re-Tweet
Share on LinkedIn

Forager Capital Makes $4.80 Per Share All-Cash Bid for RPAY—Board Faces Buyout Decision at 75% Premium

Proposal Sets 75% Premium Over RPAY’s 30-Day Average—What’s Driving the Offer?

Repay Holdings Corporation (NASDAQ:RPAY) received a significant acquisition bid today as Forager Capital Management, already the company’s largest shareholder at 13% ownership, put forward a proposal to purchase all outstanding shares for $4.80 in cash. This offer stands in sharp contrast to RPAY’s recent trading history, representing a striking 75% premium over the company’s 30-day volume-weighted average price of $2.75.

Forager Capital Moves Quickly After Board Response—Takeover Tensions Rise

The story unfolded rapidly. Just days before making the bid public, Forager’s initial exploratory approach was met with immediate resistance, as RPAY’s board adopted a shareholder rights plan (often called a ‘poison pill’) less than 24 hours after initial outreach. Forager’s public letter suggests frustration with this defensive action and a desire to spur constructive negotiations.

Forager is emphasizing certainty and speed in its bid, touting sufficient financing and a strong record—their most recent acquisition, Quipt Home Medical, was completed efficiently last month at a $260 million valuation.

Deal Details: Cash Offer Terms, Conditions, and Timeline

Shareholders stand to benefit from a cash exit at a substantial premium. Forager’s offer has no financing contingency and is subject only to standard regulatory approvals and a definitive merger agreement. The buyout would take the company private, aiming to eliminate the market distractions and costs associated with being public.

Term Details
Buyer Forager Capital Management, LLC
Offering Price $4.80 per share (all cash)
Premium to 30-day VWAP 75%
Ownership Position ~13% of RPAY shares
Financing Condition None (funds secured)
Recent Acquisition Record Quipt Home Medical ($260M)

Board’s Decision Looms—What Does This Mean for Investors?

For shareholders, the offer provides a rare opportunity: immediate liquidity at a healthy premium and the certainty of cash in hand. Yet, the board’s swift defensive move suggests internal debate about value and strategy. In the short term, investors will watch closely for the board's official response and the possibility of rival bids emerging.

Forager’s confidence is evident—they want to move fast, have engaged legal advisors, and highlight their readiness for due diligence. The next phase will likely bring clarity on whether negotiations turn collaborative or combative, and whether shareholders will push for a deal that crystallizes value in a challenging environment for small-cap public companies.

Key Takeaway: Premium Buyout Proposal Puts Board and Shareholders at a Crossroads

The $4.80 per share offer from Forager Capital reshapes the near-term outlook for RPAY. With a credible buyer at the table and 13% of shares already in hand, the ball is in the board’s court. Investors should be alert for upcoming statements from both sides—because the outcome could set off more moves in the small-cap M&A landscape.


Contact Information:

If you have feedback or concerns about the content, please feel free to reach out to us via email at support@marketchameleon.com.


About the Publisher - Marketchameleon.com:

Marketchameleon is a comprehensive financial research and analysis website specializing in stock and options markets. We leverage extensive data, models, and analytics to provide valuable insights into these markets. Our primary goal is to assist traders in identifying potential market developments and assessing potential risks and rewards.


NOTE: Stock and option trading involves risk that may not be suitable for all investors. Examples contained within this report are simulated and may have limitations. Average returns and occurrences are calculated from snapshots of market mid-point prices and were not actually executed, so they do not reflect actual trades, fees, or execution costs. This report is for informational purposes only, and is not intended to be a recommendation to buy or sell any security. Neither Market Chameleon nor any other party makes warranties regarding results from its usage. Past performance does not guarantee future results. Please consult a financial advisor before executing any trades. You can read more about option risks and characteristics at theocc.com.


The information is provided for informational purposes only and should not be construed as investment advice. All stock price information is provided and transmitted as received from independent third-party data sources. The Information should only be used as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments and trading strategies. The Company does not guarantee the accuracy, completeness or timeliness of the Information.


Disclosure: This article was generated with the assistance of AI

Market Data Delayed 15 Minutes